BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sense Proteomic Limited Appoints The Sage Group as Business Development Consultants


7/23/2008 1:49:32 PM

Maidenhead, UK: July 22, 2008, Sense Proteomic Ltd. today announced the appointment of The Sage Group as its business development consultant to assist in generating additional biomarker discovery partners. Building on its two external collaborations and its internal discovery programmes, Sense now hopes to partner with additional companies to fully exploit the power of its biomarker discovery platform.

Commenting on the appointment, Chris Lyddon, joint CEO, said, "We are pleased to be working with The Sage Group given their track record and their commercial expertise in the biomarker field. We believe discovery partners will shorten development timelines of both clinical diagnostics and biomarkers for clinical trials monitoring by applying our unique autoantibody biomarker technology."

Dr. Bill Mason, Executive Director of The Sage Healthcare Group added, "Sense's novel approach will allow diagnostic and pharmaceutical companies to develop more predictive markers in the important areas of cancer and autoimmune diseases. We are pleased to be working with them to help them achieve their goals."

About Sense Proteomic Limited

Sense Proteomic is a biomarker discovery company utilising its proprietary protein array technology to discover and commercialise auto antibody biomarkers for cancer and autoimmune diseases.

About The Sage Group

The Sage Group is a leader in the provision of strategic and transactional advice to healthcare and life science companies in the diagnostics, medical device, pharmaceutical, biotechnology, life science and analytical instrument fields.

Contact

Chris Lyddon - Joint CEO
Sense Proteomic Limited
Tel: +44 (0)1628 513 500
chris.lyddon@senseproteomic.com

Dr. Bill Mason - Executive Director
Sage Healthcare Limited
Tel: +44 (0)1223 844128
wtm@sagehealthcare.com

Wayne Pambianchi - Executive Director
The Sage Group Inc.
Tel: +1 (908) 2319644
wpambianch@aol.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES